Glenmark API is the Active Pharmaceutical Ingredient manufacturing arm and a stand alone business of Glenmark Generics.

Conceived in 2001, the API business was a result of a strategic decision undertaken by the company to support Glenmark's emergence as an integrated pharmaceutical business. Today, Glenmark has API presence in over 80 countries.

At Glenmark, our goal is to cultivate long term strategies for our APIs with partners and work conjunctively to develop products that are commercially sound and scientifically viable. With over 100 process patents, we offer a rich portfolio of diverse products in a state-of-the-art manufacturing facility that offers the ability to create customized scalable solutions for drug development needs. Glenmark API is equipped to provide support spanning Analytical to Regulatory filings on a global basis.